How the public views clinical research is increasingly important for biopharma organisations, as removing barriers to trial progress can deliver huge value across the healthcare ecosystem through faster access to treatments.
Trial recruitment and retention challenges have their roots in the perception that clinical research is difficult, lengthy and invasive. But there is cause for optimism.
We recently spoke to 2,000 members of the US public to understand their feelings towards more innovative ways to participate in clinical research.
Check out the rest of the feature here
